UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000017439
Receipt No. R000020218
Scientific Title Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
Date of disclosure of the study information 2015/08/01
Last modified on 2016/05/07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
Acronym Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
Scientific Title Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
Scientific Title:Acronym Laser thermotherapy for radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
Region
Japan

Condition
Condition Patients with radioresistant cervical cancer after radiotherapy with or without chemotherapy, or for local recurrence of vagina stump after radiotherapy
Classification by specialty
Obsterics and gynecology Radiology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate clinical safety and performance testing of the newly
developed laser thermotherapy equipment
for patients with radioresistant cervical cancer after radiotherapy
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Assessment of safety
-Measured by incidence of adverse events
before, in and after treatment and until 6 months after the treatment.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment Maneuver
Interventions/Control_1 The newly developed laser thermotherapy
equipment

1. Thermotherapy is one time a week.
2. Heating time is from 40 to 50
minutes at 43-45 degrees.
3. Thermotherapy is done 5 or 6 times.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria (1)A patient with superficial lesion and a little tumor amount.
(2)A patient with no recurrent lesion except for recurrence of uterine cervix in pelvis, or a patients with an expected survival of more than 6 months after this treatment.
(3)A patient without distant metastasis.
(4))A patient with difficulty of additional radiation therapy.
(5)A patient with difficulty of operation or with refusal of operation.
(6)A patient without indication of chemotherapy or with refusal of chemotherapy.
(7)A patient who has been diagnosed with recurrent or residual cancer of the uterine cervix based on histology (biopsy).
(8)A patient who has squamous cell carcinoma, adenosquamous cell carcinoma, or adenocarcinoma is limited.
(9)A patient with an expected survival of more than 6 months.
(10)A female patient aged 20 years or older at the time of enrollment and a patient who has provided written informed consent to partcipate in this study.
Key exclusion criteria (1)A patient who cannot be inserted this equipment through the vagina and can be hard to attain to a lesion.
(2)A patient with collagen disease.
(3)A patient with active double cancer.
(4)A patient whom the investigator considers to be ineligible as a subject.
Target sample size 5

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoshiyuki Itoh
Organization Nagoya University Graduate School of Medicine
Division name Therapeutic Radiology
Zip code
Address 65 Tsurumai-cho, Showa-ku, Nagoya
TEL 052-744-2544
Email itoh@med.nagoya-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yoshiyuki Itoh
Organization Nagoya University Hospital
Division name Dept. of Radiology
Zip code
Address 65 Tsurumai-cho, Showa-ku, Nagoya
TEL 052-744-2328
Homepage URL
Email itoh@med.nagoya-u.ac.jp

Sponsor
Institute Nagoya University Hospital
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 08 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2015 Year 07 Month 25 Day
Date of IRB
Anticipated trial start date
2015 Year 08 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 05 Month 07 Day
Last modified on
2016 Year 05 Month 07 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020218

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.